Several researchers from our group were in attendance at The American Society of Bone and Mineral Research (ASBMR) Annual Meeting held in Baltimore MD last week (Oct 4-7). We presented the latest findings from our ongoing research studies, including atypical femur fractures, ankylosing spondilytis, vibration therapy, nutrition and body composition and more. We’ll be talking about these findings on this blog in the near future, but in the meanwhile, here are some of our colleagues at work at ASBMR.
(Click on the images to view full size)
Dr. Angela M. Cheung, Director of University Health Network/Mount Sinai Hospital Osteoporosis Program, next to a poster describing outcomes such as quality of life, pain, and disability in individuals who are part of the Ontario Atypical Femur Fracture (AFF) Cohort.
Dr. Cheung presenting the findings of our research on fracture healing in patients with incomplete atypical femur fractures.
Endocronologist and staff at the Osteoporosis Clinic, Dr. Rowena Ridout, next to a poster describing our study on the effectiveness of detecting incomplete atypical femur fractures on a DXA machine (most commonly used to test bone mineral density).
Dr. Marta Erlandson, Postdoctoral Fellow, next to a poster describing her research on measuring different properties of muscle on a new imaging technology.
Dr. Miranda Boggild, Medical Trainee in Internal Medicine and a research student of Dr. Cheung, presenting her research on whether whole body vibration therapy has any effects on muscle in postmenopausal women with low bone density.
Dr. Boggild’s poster, outlining the details of her research findings.
Dr. Olga Gajic-Veljanoski, researcher at the Osteoporosis Program, next to her poster on using a particular statistical method to determine whether the drug Odanacatib can prevent fractures and reduce bone loss.
Dr. Maryam S Hamidi, Scientific Associate at the Osteoporosis Program with Dr. Cheung, next to her poster describing her findings on the relationship between Vitamin B12, folate, and iron and body composition.
Dr. Hamidi talking about her research findings.
Dr. Nisha Nigil Haroon, Clinical Fellow at the Osteoporosis Program, next to her poster describing the effect that medication (TNF inhibitors) used to treat ankylosing spondylitis (AS) has on bone density and whether this class of medications can be used to treat bone loss in patients with AS.
Our team at ASBMR 2013. From left: Dr. Marta Erlandson, Dr. Olga Gajic-Veljanoski, Dr. Nisha Nigil Haroon, Dr. Maryam S Hamidi, and Dr. Miranda Boggild.